Annual EBITDA
$1.69B$460.76M+37.49%
Summary
- Current Value
- As of today, GRFS annual EBITDA is $1.69B, up +37.49% on
- Historical Performance
- GRFS annual EBITDA is up +55.84% over the past 3 years, and up +5.97% over the past 5 years
- All-Time High Comparison
- GRFS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GRFS annual EBITDA is +47.05% above its 3-year low of $1.15B reached on an earlier date
- Sector Comparison
- GRFS annual EBITDA is higher than 95.50% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.69B | +37.5% | +55.8% | +6.0% | +359.3% | |
| Quarterly EBITDA | $531.14M | +13.0% | +74.5% | +9.4% | +515.9% | |
| TTM EBITDA | $1.97B | +26.7% | +246.2% | +29.7% | +2182.8% | |
| Price | $9.49 | +24.9% | +6.4% | -51.6% | – | |
| PE Ratio | 15.45 | -49.3% | -77.0% | -18.1% | – | |
| Annual Revenue | $7.80B | +9.5% | +33.8% | +36.7% | +514.4% | |
| Annual EPS | $0.25 | +270.2% | -24.1% | -75.6% | +100.0% | |
| Annual EBIT | $1.22B | +62.9% | +84.5% | -3.2% | +288.7% | |
| Annual Net Income | $230.19M | +30.1% | -26.6% | -68.3% | +12.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.69B | at high | |
| 5Y | $1.69B | at high | |
| All | $1.69B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.15B | N/A | +47.0% |
| 5Y | $1.08B | +55.8% | |
| All | $56.01M | +2917.1% |
EBITDA History
FAQ
What is the current annual EBITDA of GRFS?
As of today, GRFS annual EBITDA is $1.69B
What is 1-year change in GRFS annual EBITDA?
GRFS annual EBITDA is up +37.49% year-over-year
What is 3-year change in GRFS annual EBITDA?
GRFS annual EBITDA is up +55.84% over the past 3 years
How far is GRFS annual EBITDA from its all-time high?
GRFS annual EBITDA is currently at its all-time high
How does GRFS annual EBITDA rank versus sector peers?
GRFS annual EBITDA is higher than 95.50% of companies in Healthcare sector
When is GRFS next annual earnings release?
The next annual earnings release for GRFS is on
Quarterly EBITDA
$531.14M$24.65M+4.87%
Summary
- Current Value
- As of today, GRFS quarterly EBITDA is $531.14M, up +4.87% on
- Historical Performance
- GRFS quarterly EBITDA is up +13.02% year-over-year, and up +74.46% over the past 3 years
- All-Time High Comparison
- GRFS quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GRFS quarterly EBITDA is +101.09% above its 3-year low of $264.13M reached on an earlier date
- Sector Comparison
- GRFS quarterly EBITDA is higher than 95.39% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $531.14M | +4.9% | +13.0% | +74.5% | +9.4% | |
| Annual EBITDA | $1.69B | – | +37.5% | +55.8% | +6.0% | |
| TTM EBITDA | $1.97B | +3.2% | +26.7% | +246.2% | +29.7% | |
| Price | $9.49 | 0.0% | +24.9% | +6.4% | -51.6% | |
| PE Ratio | 15.45 | 0.0% | -49.3% | -77.0% | -18.1% | |
| Quarterly Revenue | $2.18B | +1.6% | +10.7% | +31.7% | +37.8% | |
| Quarterly EPS | $0.22 | +11.7% | +161.1% | +1399.4% | -52.2% | |
| Quarterly EBIT | $410.96M | +3.6% | +17.1% | +137.6% | +5.1% | |
| Quarterly Net Income | $167.60M | +6.8% | +86.1% | +1118.3% | -49.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $531.14M | at high | |
| 3Y | $531.14M | at high | |
| 5Y | $531.14M | at high | |
| All | $531.14M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $405.96M | +30.8% | |
| 3Y | $264.13M | N/A | +101.1% |
| 5Y | $264.13M | +101.1% | |
| All | $42.51M | +1149.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GRFS?
As of today, GRFS quarterly EBITDA is $531.14M
What is GRFS quarterly EBITDA most recent change?
GRFS quarterly EBITDA was up +4.87% on September 1, 2025
What is 1-year change in GRFS quarterly EBITDA?
GRFS quarterly EBITDA is up +13.02% year-over-year
How far is GRFS quarterly EBITDA from its all-time high?
GRFS quarterly EBITDA is currently at its all-time high
How does GRFS quarterly EBITDA rank versus sector peers?
GRFS quarterly EBITDA is higher than 95.39% of companies in Healthcare sector
When is GRFS next earnings release?
The next earnings release for GRFS is on
TTM EBITDA
$1.97B$61.17M+3.21%
Summary
- Current Value
- As of today, GRFS TTM EBITDA is $1.97B, up +3.21% on
- Historical Performance
- GRFS TTM EBITDA is up +26.69% year-over-year, and up +246.23% over the past 3 years
- All-Time High Comparison
- GRFS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GRFS TTM EBITDA is +645.30% above its 3-year low of $264.13M reached on an earlier date
- Sector Comparison
- GRFS TTM EBITDA is higher than 95.39% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.97B | +3.2% | +26.7% | +246.2% | +29.7% | |
| Annual EBITDA | $1.69B | – | +37.5% | +55.8% | +6.0% | |
| Quarterly EBITDA | $531.14M | +4.9% | +13.0% | +74.5% | +9.4% | |
| Price | $9.49 | 0.0% | +24.9% | +6.4% | -51.6% | |
| PE Ratio | 15.45 | 0.0% | -49.3% | -77.0% | -18.1% | |
| TTM Revenue | $8.31B | +2.6% | +9.4% | +159.9% | +37.7% | |
| TTM EPS | $0.61 | +28.1% | +166.1% | +428.1% | -45.9% | |
| TTM EBIT | $1.50B | +4.2% | +39.0% | +236.8% | +29.3% | |
| TTM Net Income | $511.22M | +17.9% | +127.1% | +391.1% | -39.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.97B | at high | |
| 3Y | $1.97B | at high | |
| 5Y | $1.97B | at high | |
| All | $1.97B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.72B | N/A | +14.4% |
| 3Y | $264.13M | N/A | +645.3% |
| 5Y | $264.13M | +645.3% | |
| All | $86.23M | +2182.8% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GRFS?
As of today, GRFS TTM EBITDA is $1.97B
What is GRFS TTM EBITDA most recent change?
GRFS TTM EBITDA was up +3.21% on September 1, 2025
What is 1-year change in GRFS TTM EBITDA?
GRFS TTM EBITDA is up +26.69% year-over-year
How far is GRFS TTM EBITDA from its all-time high?
GRFS TTM EBITDA is currently at its all-time high
How does GRFS TTM EBITDA rank versus sector peers?
GRFS TTM EBITDA is higher than 95.39% of companies in Healthcare sector
When is GRFS next earnings release?
The next earnings release for GRFS is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- GRFS Official Website www.grifols.com
- GRFS Profile on Yahoo Finance finance.yahoo.com/quote/GRFS
- GRFS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/grfs